P.S. Sears

Fidaxomicin versus Vancomycin for <i>Clostridium difficile</i> Infection

Thomas Louie, Mark A. Miller, Kathleen M. Mullane et al. · New England Journal of Medicine · 2011 · 1.6K citations · Full text

Medicine, Infectious Diseases, Pharmacology +11

Fidaxomicin versus vancomycin for infection with Clostridium difficile in Europe, Canada, and the USA: a double-blind, non-inferiority, randomised controlled trial

Oliver A. Cornely, Derrick W. Crook, Roberto Esposito et al. · The Lancet Infectious Diseases · 2012 · 752 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +13

Carbohydrate Mimetics: A New Strategy for Tackling the Problem of Carbohydrate-Mediated Biological Recognition

P.S. Sears, Chi‐Huey Wong · Angewandte Chemie International Edition · 1999 · 510 citations

Life Sciences, Biochemistry, Molecular Biology +16

Efficacy of Fidaxomicin Versus Vancomycin as Therapy for Clostridium difficile Infection in Individuals Taking Concomitant Antibiotics for Other Concurrent Infections

Kathleen M. Mullane, Mark A. Miller, Karl Heinz Weiss et al. · Clinical Infectious Diseases · 2011 · 241 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +11

Design and Synthesis of New Aminoglycoside Antibiotics Containing Neamine as an Optimal Core Structure:  Correlation of Antibiotic Activity with in Vitro Inhibition of Translation

William A. Greenberg, E. Scott Priestley, P.S. Sears et al. · Journal of the American Chemical Society · 1999 · 216 citations

Pharmacy, Biochemistry, Pharmacology +17